Calendar of events NEUROLOGY
|
|
|
- Wilfrid Eaton
- 10 years ago
- Views:
Transcription
1 Calendar of events 2016 NEUROLOGY
2 Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the main neurodegenerative and reparative strategies in MS Bari, Italy 5 February 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the main neurodegenerative and reparative strategies in MS Siena, Italy February 2016 Clinical and research applications of MRI for MS diagnosis and monitoring AND WITH AN INTEREST IN MRI Illustrate and apply MRI diagnostic criteria Explain the key elements of differential diagnosis in MRI Describe basic principles and applications of quantitative MRI MS Clinic and Department of Neurology, Istanbul University, Istanbul, Turkey March 2016 Hands-on clinical management of adult and paediatric MS NEUROLOGISTS INTERESTED IN MS Illustrate and apply MS diagnostic criteria Describe pros and cons of current MS treatments Perform differential diagnosis in paediatric cases
3 Middle East location to be defined March 2016 MS for neurologists, MS specialists and nurses NEUROLOGISTS, MS SPECIALISTS AND NURSES INTERNATIONAL CONFERENCE Berlin, Germany 9-10 April Annual conference in MS NEUROLOGISTS MANAGING MS PATIENTS Describe the main advances in MS pathogenesis Discuss the role of different tools in MS diagnosis, monitoring and treatment choices Review the mechanisms of neurodegeneration and repair Cemcat, Barcelona, Spain June 2016 Updates in MS knowledge CLINICIANS INVOLVED IN MS MANAGEMENT AND NEUROLOGISTS ENTERING THE MS FIELD Describe the role of environmental factors in MS onset and the main pathophysiological mechanisms of MS Illustrate and apply past and present diagnostic criteria for MS Use clinical and radiological markers of disease severity to define treatment response Compare the mechanisms of action and safety profile of all MS treatments MS Clinic and Department of Neurology, Istanbul University, Istanbul, Turkey June 2016 Hands-on clinical management of adult and paediatric MS NEUROLOGISTS INTERESTED IN THE MS FIELD Illustrate and apply MS diagnostic criteria Describe pros and cons of current MS treatments Perform differential diagnosis in paediatric cases
4 London, UK 13 September 2016 MS Academia: Updates on MS treatment and management (pre-ectrims) NEUROLOGISTS SPECIALIZED IN MS AND OTHER CLINICIANS WITH A SPECIAL INTEREST OR FOCUS ON MS Investigate genetic and environmental factors in the pathogenesis of multiple sclerosis Integrate clinical, neurophysiologic, and MRI findings into disease diagnosis Incorporate information about risks and benefits of currently available drugs in treatment decision-making London, UK 13 September th MS Nurse international workshop (pre-ectrims) NURSES INVOLVED IN THE TREATMENT OF PATIENTS WITH MS Summarize the role of the MS nurse in the evolving scenario of the multidisciplinary approach to MS Describe the specific needs of progressive MS patients and explain how to handle them from the nurse s perspective Define the concept of compliance and adherence with respect to old and new drugs and offer main strategies to improve adherence List the short and long term monitoring requirements for each MS treatment Europe - Location to be determined September 2016 Treatment and Neuro- Myelitis Optica NEUROLOGISTS INVOLVED IN THE TREATMENT OF MS S. Raffaele Hospital, Milan, Italy October 2016 In-depth MRI techniques and analysis in multiple sclerosis YOUNG CLINICIANS AND SCIENTISTS CURRENTLY INVOLVED IN MS MANAGEMENT AS WELL AS RADIOLOGISTS INTERESTED IN MS Describe the present MRI diagnostic criteria for MS Summarize the novel, functional and structural markers of disease severity obtained through advanced MRI techniques Illustrate the main findings of functional MRI techniques Describe the main software for imaging postprocessing and basic principles of quantitative analysis in MRI imaging
5 Valens Clinic, Valens, Switzerland October 2016 New frontiers in MS rehabilitation NEUROLOGISTS, PHYSIATRISTS AND PHYSIOTERAPISTS INVOLVED IN MS Describe the neurophysiological basis of rehabilitation and the benefit of exercise for neuronal survival Detail the most suitable metrics to measure motor and cerebellar dysfunction in both relapsing-remitting and progressive MS List the key clinical elements needed to project an individualized rehabilitation plan Illustrate frequently used tools to diagnose cognitive impairment and look at the main strategies for cognitive rehabilitation Buenos Aires, Argentina 16 November 2016 Regional update in MS (pre-lactrims) SPANISH SPEAKING NEUROLOGISTS, MAINLY COMING FROM LATIN AMERICA, TREATING PATIENTS WITH MS
AUBMC Multiple Sclerosis Center
AUBMC Multiple Sclerosis Center 1 AUBMC Multiple Sclerosis Center The vision of the American University of Beirut Medical Center (AUBMC) is to be the leading academic medical center in Lebanon and the
13 September 2016 - London, UK
INTERNATIONAL WORKSHOP PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 13 September 2016 - London, UK MS Academia - Multiple sclerosis advanced course Overview Multiple sclerosis
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
MS: from disease management to patient management
2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain 18-19 May 2012 Dear Colleague On behalf of the Serono Symposia International Foundation we
5 February 2016 - Bari, Italy
Updates on MS treatment management 5 February 2016 - Bari, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
29 January 2016 - Rome, Italy
Updates on MS treatment management 29 January 2016 - Rome, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
Mellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
Nutrition support in neurodegenerative diseases
ESPEN Congress Leipzig 2013 The ESPEN Guidelines session Nutrition support in neurodegenerative diseases R. Burgos (ES) ESPEN GUIDELINES ON NUTRITION SUPPORT IN NEURODEGENERATIVE DISORDERS Dr. Rosa Burgos
MS-NEED: Multiple Sclerosis-Nurse Empowering Education
MS-NEED: Multiple Sclerosis-Nurse Empowering Education European Multiple Sclerosis Platform Rehabilitation in Multiple Sclerosis International Organisation of Multiple Sclerosis Nurses Objectives of MS-NEED
Policy proposals to improve access to multiple sclerosis treatments in Europe
Policy proposals to improve access to multiple sclerosis treatments in Europe Key findings and conclusions EMSP Conference Oslo, 17 May 2016 This research builds on a study conducted by CRA in 2014 There
ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS
ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS i. Summary The National Service Framework for long-term neurological conditions categorises neurological conditions as: Sudden-onset conditions
ACUTE STROKE PATHWAY
ACUTE STROKE PATHWAY THERE IS A NEED FOR STATEWIDE STROKE SYSTEM OF CARE ALL MISSISSIPPIANS SHOULD BE ABLE TO ACCESS NEW PROTOCOLS FOR STROKE TREATMENT JOINT EFFORT WITH EMS, PHYSICIANS, HOSPITALS AND
OhioHealth Neuroscience
SEPTEMBER/OCTOBER 2013 OhioHealth Neuroscience CLINICAL UPDATE IN THIS ISSUE: NEW SERVICES OhioHealth advancing many of its programs across the neuroscience continuum of care NEW FACILITY OhioHealth Rehabilitaton
The Importance of Educational Access for MS Nurses: Integrating Knowledge & Skills MS Nurse PROfessional
The Importance of Educational Access for MS Nurses: Integrating Knowledge & Skills MS Nurse PROfessional Vicki Matthews, RIMS Specialist Nurse Advisor This activity is supported by educational grants from:
Understanding Relapse in Multiple Sclerosis. A guide for people with MS and their families
Understanding Relapse in Multiple Sclerosis A guide for people with MS and their families Introduction You have been given this booklet because you have been diagnosed with Multiple Sclerosis (MS) and
Advanced Dental Practice Management Programme
Advanced Dental Practice Management Programme INDEX 1. INTRODUCTION 2. OBJECTIVES AND TARGETS 3. METHODOLOGY 4. CONTENT 5. PROGRAMME DIRECTOR 6. ESADE 7. WHY ESADE BUSINESS SCHOOL? 8. SPANISH SOCIETY OF
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070277/ Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
Global Economic Impact of Multiple Sclerosis
Global Economic Impact of Multiple Sclerosis May 2010 Literature Review Executive Summary Prepared for Multiple Sclerosis International Federation London, United Kingdom Prepared by Michael Trisolini,
Relapsing-remitting multiple sclerosis Ambulatory with or without aid
AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date
FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov
FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative
Healthcare Technology Management (HTM)
Healthcare Technology Management (HTM) Izabella A. Gieras, MS, MBA President, ACCE Clinical Engineering Manager William Beaumont Hospital Beaumont Services Company Michigan, U.S.A. Advanced Clinical Engineering
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP9 Access to Innovative Technologies Medical Imaging Task 9.2: Organization of a European
2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
PGY 206 ELEMENTARY PHYSIOLOGY. (3) An introductory survey course in basic human physiology. Prereq: One semester of college biology.
206 ELEMENTARY PHYSIOLOGY. (3) An introductory survey course in basic human physiology. Prereq: One semester of college biology. 207 CASE STUDIES IN PHYSIOLOGY. (1) Group discussions of clinical cases
Review Date: March 2012. Issue Status: Approved Issue No: 2 Issue Date: March 2010
Title: Multiple Sclerosis guidelines for the use of beta-interferon, glatiramer acetate, natalizumab, mitoxantrone and other disease Authors Name: Dr P Talbot Contact Name: Dr Paul Talbot Contact Phone
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10
5. Diagnosis Questions to be answered: 5.1. What are the diagnostic criteria for ADHD in children and adolescents? 5.2. How is ADHD diagnosed in children and adolescents? Who must diagnose it? 5.3. Which
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS? Marie Trad, M.D., Lynne Hughes, Cathy VanBelle, Amy Del Medico 3rd International
MS IN EUROPE Overview of the
CHANGING THE LANDSCAPE OF MS IN EUROPE Overview of the EMSP 2015-2020 Strategic Plan The Voice of People Living with MS in Europe The European Multiple Sclerosis Platform (EMSP) exists to improve the quality
Ontario Reimburses CIS Indication for REBIF, a First-Line Treatment for Multiple Sclerosis
May 25, 2015 Contact: Shikha Virdi 905-919-0200 ext. 5504 Ontario Reimburses CIS Indication for REBIF, a First-Line Treatment for Multiple Sclerosis Rebif now reimbursed under Ontario Drug Benefit Program
EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES
EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference
MA IN REHABILITATION IN LANGUAGE AND SPEECH PATHOLOGY (TAUGHT IN BULGARIAN)
MA IN REHABILITATION IN LANGUAGE AND SPEECH PATHOLOGY (TAUGHT IN BULGARIAN) Brief presentation of the program: The program is aimed at training specialists in treatment of children, adolescents and adults
Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.
REPORT Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F. Strasser, CH 13-14 March 2015 Barcelona, Spain The Conference Cachexia
Medical Device Reporting. Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration
Medical Device Reporting Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration Session Overview Purpose: To provide information about the
UCLA Department of Neurology Outpatient Subspecialty Rotation West LA VA and Westwood Campus 300 UCLA Medical Plaza
Rotation Overview: UCLA Department of Neurology Outpatient Subspecialty Rotation West LA VA and Westwood Campus 300 UCLA Medical Plaza Outpatient Neurological Services at the UCLA Westwood and the West
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
Clinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012. Reference : NHSCB/D4/c/1
Clinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012 Reference : NHSCB/D4/c/1 NHS Commissioning Board Clinical Commissioning Policy: Disease
Lewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
Department of Neurology and Neurosurgery Clinical and Clinical Research Fellowship Application Form
Department of Neurology and Neurosurgery Clinical and Clinical Research Fellowship Application Form Fellowship in Multiple Sclerosis and Neuroinflammatory Disorders Type of Fellowship: Clinical Research
Università Vita-Salute San Raffaele. Prof. Lorenzo Dagna Delegate for International Relations Milan, October 3 rd 2011
Università Vita-Salute San Raffaele Prof. Lorenzo Dagna Delegate for International Relations Milan, October 3 rd 2011 Faculty of Medicine Faculty of Philosophy Faculty of Psychology Università Vita-Salute
The Brain and Spine CenTer
The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas
Improving quality, protecting patients
Improving quality, protecting patients Standards of proficiency for Healthcare Science Practitioners 31 July 2014 Version 1.0 Review date: 31 July 2015 Foreword I am pleased to present the Academy for
ß-interferon and. ABN Guidelines for 2007 Treatment of Multiple Sclerosis with. Glatiramer Acetate
ABN Guidelines for 2007 Treatment of Multiple Sclerosis with ß-interferon and Glatiramer Acetate Published by the Association of British Neurologists Ormond House, 27 Boswell Street, London WC1N 3JZ Contents
Master of Chiropractic (MChiro) and Pre-Chiropractic Foundation Year International and EU Edition
Master of Chiropractic (MChiro) and Pre-Chiropractic Foundation Year International and EU Edition www.southwales.ac.uk/chiro Chiropractic Courses Welcome to Chiropractic at the University of South Wales
Clinically isolated syndrome (CIS)
Clinically isolated syndrome (CIS) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION Michael K. Racke, MD Professor and Chairman in Neurology The Helen C. Kurtz Chair in Neurology Department of Neurology Ohio State University
Natalizumab (Tysabri) and PMLthe current figures. Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY
Natalizumab (Tysabri) and PMLthe current figures Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str. 51-59 63225 Langen GERMANY Humanised MAB Natalizumab Specific binding to a4-integrin
Putting the Cart Back Behind the Horse: Converting a population based research database into an electronic clinical patient record
Putting the Cart Back Behind the Horse: Converting a population based research database into an electronic clinical patient record The Story Crash course on Multiple Sclerosis A little bit of History of
PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15
PCORI Workshop on Treatment for Multiple Sclerosis Breakout Group Topics and Questions Draft 3-27-15 Group 1 - Comparison across DMTs, including differential effects in subgroups Consolidated straw man
Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
A Definition of Multiple Sclerosis
English 182 READING PRACTICE by Alyx Meltzer, Spring 2009 Vocabulary Preview (see bolded, underlined words) gait: (n) a particular way of walking transient: (adj) temporary; synonym = transitory remission:
Why study clinical neuropsychology?
University Leiden, The Netherlands Master (MSc) in Clinical Neuropsychology [email protected] www.neuropsychologie.leidenuniv.nl Why study clinical neuropsychology? You are interested in: brain/behavior
The Genetic Basis of Neurological Disorders
The Genetic Basis of Neurological Disorders A complete advanced undergraduate/graduate course with: 22 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects
The Nuts and Bolts of Multiple Sclerosis. Rebecca Milholland, M.D., Ph.D. Center for Neurosciences
The Nuts and Bolts of Multiple Sclerosis Rebecca Milholland, M.D., Ph.D. Center for Neurosciences Objectives Discuss which patients are at risk for Multiple Sclerosis Discuss the diagnostic criteria for
TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing
TESTING GUIDELINES PerformCare: HealthChoices Guidelines for Psychological Testing Testing of personality characteristics, symptom levels, intellectual level or functional capacity is sometimes medically
Kazakhstan Azerbaijan. 12 April 2016 14 April 2016
Kazakhstan Azerbaijan 12 April 2016 14 April 2016 B2B Luxury & MICE Workshop WHAT IS IT? B2B Luxury & MICE workshop provides you a unique opportunity to meet with the top-tier local buyers from Azerbaijan
Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070278/ Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
Alternatives to Hospital: Models of Integrated Care
Alternatives to Hospital: Models of Integrated Care Tom Bowen The Balance of Care Group www.balanceofcare.com IMA Health 2007, London, UK 2 April 2007 Projects taking whole systems approach Sheffield Designed
Your Time on the Island The Role of the Stroke Coordinator
Your Time on the Island The Role of the Stroke Coordinator Andrea Jaeger, MHA, BSN, CNRN Original Presentation by: Alex Graves, MS, ANP 1 Presenter Disclosure Information Andrea Jaeger, MHA, BSN, CNRN
Global Haemophilia Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070298/ Global Haemophilia Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of its Haemophilia
Rehabilitation and the role of carers
Rehabilitation and the role of carers Dr Jacinta Morgan Consultant in Rehabilitation Medicine National Clinical Lead, Rehabilitation Medicine Programme (HSE CSPD) EMSP Spring Conference Gibson Hotel Dublin,
Multiple Sclerosis Fellowship Neurology Department University of Texas Southwestern Medical School 5323 Harry Hines Blvd., Dallas, TX 75390-8806
Multiple Sclerosis Fellowship Neurology Department University of Texas Southwestern Medical School 5323 Harry Hines Blvd., Dallas, TX 75390-8806 Program Director: Elliot M Frohman, MD, PhD., FAAN Information
Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas
Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category
Accuracy in Space and Time: Diagnosing Multiple Sclerosis. 2012 Genzyme Corporation, a Sanofi company.
Accuracy in Space and Time: Diagnosing Multiple Sclerosis 2012 Genzyme Corporation, a Sanofi company. Brought All rights to reserved. you by www.msatrium.com, MS.US.PO876.1012 your gateway to MS knowledge.
1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives
Descriptions and Neuroplasticity Health care providers are facing greater time restrictions to render services to the individual with neurological dysfunction. However, the scientific community has recognized
How To Use A Drug In Multiple Sclerosis
Revised (2009) guidelines for prescribing in multiple sclerosis INTRODUCTION In January 2001, the (ABN) first published guidelines for the use of licensed disease modifying treatments (ß-interferon and
Rehabilitation Medicine Service for Adults with Physical Disabilities
Rehabilitation Medicine Service for Adults with Physical Disabilities Information for Professionals Rehabilitation Medicine Service Community & Therapy Services Group This leaflet has been designed to
Guide to Assessment Scales in Parkinson s Disease
Guide to Assessment Scales in Parkinson s Disease Pablo Martinez-Martin Research Unit, Alzheimer Centre Reina Sofia Foundation and Centre for Networked Biomedical Research on Neurodegenerative Diseases
Profile: Kessler Patients
Profile: Kessler Patients 65 Breakthrough Years Kessler Institute has pioneered the course of medical rehabilitation since 1948. Today, as the nation s largest single rehabilitation hospital, we continue
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,
PART I DEPARTMENT OF PERSONNEL SERVICES 6.281 STATE OF HAWAII 6.286... 6.287 6.298 Class Specifications for the
PART I DEPARTMENT OF PERSONNEL SERVICES 6.281 STATE OF HAWAII 6.286................................................................ 6.287 6.298 Class Specifications for the Series Definition: OCCUPATIONAL
06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute
The Impact of Multiple Sclerosis in the Pacific Northwest James Bowen, MD Multiple Sclerosis Center Multiple Sclerosis Center Swedish Neuroscience Institute 1 2 Motor Symptoms of MS Weakness Spasticity
Press Release Description Thread
Mass Media 9-5-2013 Press Release Description Thread Scientific Advancement by three Cypriot Scientists Hope for a new innovative treatment for Multiple Sclerosis Dear Sir/Madam, Our company, PALUPA Medical
Teleradiology at Freiburg University Hospital
Teleradiology at Freiburg University Hospital Elmar Kotter, MD, Department of Radiology Maria Onyshchenko-Dubow, International Medical Services Ernst Pelikan, Hospital Computer Centre Universitätsklinikum
Advances towards Remote Assessment of Disease and Relapse in Multiple Sclerosis
Advances towards Remote Assessment of Disease and Relapse in Multiple Sclerosis Jane Rhodes March 31 st 2016 CAMD Digital Biomarkers Conference Baltimore, MD Emerging technology for the enhancement of
Life with MS: Mastering Early Treatment
Life with MS: Mastering Early Treatment Essential Information About MS Multiple sclerosis (MS) is a disease that attacks the central nervous system (CNS). Approximately 2.5 million people worldwide and
Neurological Rehabilitation in Practice
Neurological Rehabilitation in Practice Christopher Ward Professor & Consultant in Rehabilitation Medicine University of Nottingham School of Community Health Sciences Derby Hospitals Foundation Trust
Graduate Program Objective #1 Course Objectives
1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.
Trauma Insurance Claims Seminar Invitation
Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims
